Specialties
Reports that name this provider
- Stem Cell Therapy Quality in Brazil
- ANVISA-certified GMP; first GMP cellular product manufacturing plant in Latin America; launched 2022; managed by USP and Ribeirão Preto Hemocentro
An Independent Reference on Medical Travel Abroad · Reader-Funded